PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
29-Apr-2021 Original-Research: MagForce AG (von GBC AG) MagForce AG
29-Apr-2021 Scipher Medicine Announces Program to Discover New Class of Drugs Targeting Autoimmune Patients Refractory to Existing Therapies B3C newswire
29-Apr-2021 osteolabs GmbH Establishes UK Presence B3C newswire
29-Apr-2021 Novo Seeds co-leads Adcendo’s EUR 51 Million Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers Novo Seeds
29-Apr-2021 GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for Enterprise in Innovation GW Pharmaceuticals
29-Apr-2021 Bone Therapeutics announces 2020 full year results Bone Therapeutics
29-Apr-2021 Verona Pharma Reports First Quarter 2021 Financial Results and Provides Corporate Update Verona Pharma
29-Apr-2021 Results from large-scale real-world safety study for oral combination contraception pill, Zoely® (NOMAC-E2), submitted to European Medicines Agency Theramex
29-Apr-2021 Bachem celebrates the hire of its 1000th employee at the Bubendorf site Bachem
29-Apr-2021 Asklepios Group: 2020 financial year dominated by COVID-19 pandemic and Rhön acquisition Asklepios Kliniken
29-Apr-2021 Chiesi teams up with Innovate UK award winning SMEs to improve sustainability of respiratory inhaler devices Chiesi Limited
29-Apr-2021 Advanced Biological Laboratories Receives CE-IVD Registration for its UltraGene SARS-CoV-2 Triplex Assay Advanced Biological Laboratories (ABL)
29-Apr-2021 Santhera and ReveraGen Announce New 2.5-year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy Santhera
29-Apr-2021 Vertex Announces European Commission Approval for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat Cystic Fibrosis Patients 12 Years and Older With At Least One F508del Mutation in the CFTR gene Vertex
29-Apr-2021 ProductLife Group Enters US Market with Acquisition of Leading Regulatory Drug Development Consultancy DS InPharmatics (DSI) ProductLife Group (PLG)
29-Apr-2021 Cambridge Research Biochemicals signs distribution deal with Fluoroprobes, LLC Cambridge Research Biochemicals
29-Apr-2021 APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share APONTIS PHARMA AG
29-Apr-2021 Cambridge Research Biochemicals signs distribution deal with Fluoroprobes, LLC Sciad Newswire
29-Apr-2021 Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2021 Heidelberg Pharma AG
28-Apr-2021 Invitation to MorphoSys' First Quarter Results Conference Call on May 6, 2021 MorphoSys AG